Maria Gabriella Guida
About Maria Gabriella Guida
Maria Gabriella Guida is a Medical Science Manager in Immunoscience at Bristol-Myers Squibb in New York, with extensive experience in infectious diseases.
Title
Maria Gabriella Guida is the Medical Science Manager Immunoscience at Bristol-Myers Squibb.
Current Role at Bristol-Myers Squibb
Maria Gabriella Guida has been serving as the Medical Science Manager Immunoscience at Bristol-Myers Squibb in New York, New York, United States since March 2014. Her role focuses on the medical and scientific aspects in the field of immunoscience.
Prior Experience
Before her current position, Maria Gabriella Guida briefly worked at Bristol-Myers Squibb as a Medical Science Manager Virology in 2013. Prior to joining Bristol-Myers Squibb, she served in various medical roles specializing in infectious diseases. These roles included being a specialista infettivologo at Casa Circondariale di Salerno and Casa Circondariale di Secondigliano, as well as a medico borsista specialista malattie infettive at AO D Cotugno IV Divisione.
Education and Expertise
Maria Gabriella Guida studied at Università degli Studi di Napoli Federico II, earning a laurea in Medicina e Chirurgia with a specialization in Malattie Infettive. Her education spans 11 years from 1994 to 2005. This strong educational foundation underpins her extensive experience in infectious diseases, which includes over a decade of work in various medical institutions.
Extensive Experience in Infectious Diseases
With over a decade of experience in infectious diseases, Maria Gabriella Guida has worked in multiple medical establishments. She served as a medico infettivologo at AOD Cotugno Napoli from 2005 to 2013 and held various specialist roles at the same institution, including dirigente medico, medico volontario, and medico borsista. Her expertise is further demonstrated through her consultancy role at Ospedale Psichiatrico F.Saporito di Aversa in 2008 and her work as a medico generico at SASN di Ercolano e Torre del Greco from 2008 to 2009.